|
Diabetes Care, Vol 17, Issue 7 681-687, Copyright © 1994 by American Diabetes Association
Differences in survival between black and white patients with diabetic end-stage renal disease
CC Cowie, FK Port, KF Rust and MI Harris
MPH, Social & Scientific Systems, Inc., Bethesda, MD 20814.
OBJECTIVE--To evaluate whether the longer survival of blacks with diabetic
end-stage renal disease (ESRD) relative to whites is due to racial
differences in type of diabetes, comorbidity at ESRD onset, and ESRD
treatment modality and to examine whether survival differences between
blacks and whites occur only in certain population subgroups. RESEARCH
DESIGN AND METHODS--The Michigan Kidney Registry was used to ascertain all
blacks and whites (n = 594) with diabetic ESRD in southeastern Michigan,
with ESRD onset at age < 65 years during 1974-1983. Patients were
followed through 1988. Medical records were abstracted for type of
diabetes, comorbidity at ESRD onset, and other factors. RESULTS--Median
survival among insulin-dependent diabetes mellitus patients was 27 months
in blacks and 17 months in whites, and among non-insulin-dependent diabetes
mellitus patients was 30 months in blacks and 16 months in whites. After
adjustment for confounding factors by Cox proportional hazards analysis,
the death rate was 45% lower in blacks than in whites on dialysis (relative
death rate [RDR] = 0.55, 95% confidence interval [CI] = 0.44-0.69), but was
similar in blacks and whites with a renal transplant (RDR = 0.99, 95% CI =
0.64-1.52). Compared with dialysis, transplantation was associated with
lower mortality in both races (white, RDR = 0.50, 95% CI = 0.36-0.70;
blacks, RDR = 0.89, 95% CI = 0.60-1.34), although the effect was not
statistically significant in blacks. Racial differences in survival did not
vary by type of diabetes or any additional factor. CONCLUSIONS--Survival
after ESRD onset is longer in blacks than in whites treated with dialysis,
even after adjusting for comorbidity and other factors that affect
survival. Survival does not differ by race among transplant patients.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Wolf, J. Betancourt, Y. Chang, A. Shah, M. Teng, H. Tamez, O. Gutierrez, C. A. Camargo Jr., M. Melamed, K. Norris, et al.
Impact of Activated Vitamin D and Race on Survival among Hemodialysis Patients
J. Am. Soc. Nephrol.,
July 1, 2008;
19(7):
1379 - 1388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Waikar, G. C. Curhan, J. Z. Ayanian, and G. M. Chertow
Race and Mortality after Acute Renal Failure
J. Am. Soc. Nephrol.,
October 1, 2007;
18(10):
2740 - 2748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Rodriguez, S. Sen, K. Mehta, S. Moody-Ayers, P. Bacchetti, and A. M. O'Hare
Geography Matters: Relationships among Urban Residential Segregation, Dialysis Facilities, and Patient Outcomes
Ann Intern Med,
April 3, 2007;
146(7):
493 - 501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Robinson, M. M. Joffe, R. L. Pisoni, F. K. Port, and H. I. Feldman
Revisiting Survival Differences by Race and Ethnicity among Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study
J. Am. Soc. Nephrol.,
October 1, 2006;
17(10):
2910 - 2918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. I. Freedman, D. W. Bowden, M. M. Sale, C. D. Langefeld, and S. S. Rich
Genetic Susceptibility Contributes to Renal and Cardiovascular Complications of Type 2 Diabetes Mellitus
Hypertension,
July 1, 2006;
48(1):
8 - 13.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Parnes, D. S. Main, L. M. Dickinson, L. Niebauer, S. Holcomb, J. M. Westfall, and W. D. Pace
Clinical Decisions Regarding HbA1c Results in Primary Care: A report from CaReNet and HPRN
Diabetes Care,
January 1, 2004;
27(1):
13 - 16.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Chaturvedi, J. Jarrett, N. Morrish, H. Keen, and J. H Fuller
Differences in mortality and morbidity in African Caribbean and European people with non-insulin dependent diabetes mellitus: results of 20 year follow up of a London cohort of a multinational study
BMJ,
October 5, 1996;
313(7061):
848 - 852.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1994 by the American Diabetes Association.
|
|
| |
|